Regulus (RGLS) Prospects
by popo | February 18, 2016 10:39 pm
Just wondering what thoughts were after recent news from Regulus (see Dr. KSS[1] 2/3/16 post).
Endnotes:
- Dr. KSS: https://www.stockgumshoe.com/tag/dr-kss/
Source URL: https://www.stockgumshoe.com/2016/02/microblog-regulus-rgls-prospects/
rgls hasn’t looked good since last march. stay out.
Team,
$RGLS well it sure has performed well since I acquired shares. In fact it is my only current Biotech holding in the green at +35%. Certainly still much closer to its 52 week low ($5.14) than its 52 week high ($21.22) with an average target price of $31. Like many emerging Biotechs it could also be a possible buy out candidate. Earnings on Monday but earnings are far less important with emerging Biotechs.
V/R
Tom
I am thinking along those same lines. Attractive price, possible highly successful drug making 52-week even less meaningful, possible buy-out candidate. Cash burn rate?